TENX - Tenax Therapeutics, Inc. Stock Price and Quote

TENX [NASD]

Index	-	P/E	-	EPS (ttm)	-0.48	Insider Own	9.10%	Shs Outstand	26.33M	Perf Week	-6.73%
Market Cap	4.62M	Forward P/E	-	EPS next Y	-1.79	Insider Trans	0.00%	Shs Float	8.71M	Perf Month	-24.24%
Income	-12.20M	PEG	-	EPS next Q	-2.28	Inst Own	16.30%	Short Float / Ratio	24.77% / 0.52	Perf Quarter	-77.88%
Sales	-	P/S	-	EPS this Y	-20.70%	Inst Trans	29.96%	Short Interest	2.16M	Perf Half Y	-85.72%
Book/sh	0.15	P/B	3.27	EPS next Y	106.10%	ROA	-214.10%	Target Price	43.00	Perf Year	-96.93%
Cash/sh	-	P/C	-	EPS next 5Y	-	ROE	-294.60%	52W Range	0.45 - 16.96	Perf YTD	-77.98%
Dividend	-	P/FCF	-	EPS past 5Y	44.80%	ROI	-	52W High	-97.11%	Beta	2.23
Dividend %	-	Quick Ratio	6.50	Sales past 5Y	-	Gross Margin	-	52W Low	8.54%	ATR	0.11
Employees	8	Current Ratio	6.50	Sales Q/Q	-	Oper. Margin	-	RSI (14)	34.11	Volatility	8.84% 17.84%
Optionable	No	Debt/Eq	0.00	EPS Q/Q	26.50%	Profit Margin	-	Rel Volume	0.00	Prev Close	0.49
Shortable	Yes	LT Debt/Eq	0.00	Earnings	-	Payout	-	Avg Volume	4.19M	Price	0.49
Recom	2.00	SMA20	-12.37%	SMA50	-55.21%	SMA200	-85.84%	Volume	0	Change	0.00%

May-18-17

Upgrade

Ladenburg Thalmann

Neutral → Buy

Dec-16-14

Initiated

MLV & Co

Buy

Nov-18-14

Initiated

WallachBeth

Buy

$12

Mar-22-23 08:45AM	Tenax Announces Issuance of U.S. Patent Covering Use of IV Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF) GlobeNewswire -5.36%
Feb-17-23 07:05AM	Analysts Are Optimistic We'll See A Profit From Tenax Therapeutics, Inc. (NASDAQ:TENX) Simply Wall St.
Feb-15-23 08:05AM	TENX: New Funding Puts Wind in the Sails Zacks Small Cap Research
Feb-07-23 12:10PM	Triangle pharma raising millions amid uncertain future American City Business Journals -8.02%
Feb-03-23 08:19AM	Tenax Therapeutics Announces Pricing of Approximately $15.6 Million Public Offering GlobeNewswire -20.81%
10:43AM	Loading…
Feb-02-23 10:43AM	Why Tenax Therapeutics Shares Are Gaining Today? Benzinga +30.77%
Feb-01-23 04:31PM	Tenax Granted Notice of Allowance for U.S. Patent Application Covering Use of IV Levosimendan in Pulmonary Hypertension with Heart Failure and Preserved Ejection Fraction (PH-HFpEF) GlobeNewswire -20.28%
Jan-04-23 08:00AM	Tenax Therapeutics Announces Reverse Stock Split GlobeNewswire
Nov-03-22 07:16AM	TENX: Agility Required to Unlock Considerable Upside Zacks Small Cap Research -20.03%
Oct-10-22 08:30AM	Positive Data Presented at HFSA Annual Meeting Demonstrate Effects of Oral Levosimendan in Patients with Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction (PH-HFpEF) GlobeNewswire
Sep-15-22 09:29AM	Tenax Therapeutics Stock Jumps On Strategic Alternative Review Benzinga +11.25%
08:30AM	Tenax Therapeutics Announces the Evaluation of Strategic Alternatives GlobeNewswire
Aug-28-22 09:23AM	Loss-Making Tenax Therapeutics, Inc. (NASDAQ:TENX) Expected To Breakeven In The Medium-Term Simply Wall St.
Aug-23-22 05:58AM	TENX: The Pressures On: Awaiting Phase 3 Start Zacks Small Cap Research
Jul-01-22 07:52AM	Chapel Hill company given extension to regain Nasdaq compliance American City Business Journals +6.07%
08:30AM	Loading…
May-25-22 08:30AM	Tenax Therapeutics Hosting Key Opinion Leader Webinar on TNX-201: A Potential Treatment for Pulmonary Arterial Hypertension (PAH) Business Wire
May-23-22 08:30AM	Tenax Therapeutics Announces Successful Comparative Pharmacokinetic Study of TNX-201 for the Treatment of Pulmonary Arterial Hypertension Business Wire +6.92%
May-19-22 08:18AM	TENX: 1Q:22 Financial and Operational Review Zacks Small Cap Research
May-18-22 08:30AM	Tenax Therapeutics Announces $8 Million PIPE Offering Priced At-the-Market under Nasdaq Rules Business Wire +7.27%
Apr-01-22 09:25AM	TENX: 2021 Financial and Operational Review Zacks Small Cap Research
Mar-31-22 08:30AM	Tenax Therapeutics Reports Fiscal Year 2021 Results and Provides Business Update Business Wire
Mar-30-22 05:00PM	Tenax Therapeutics Announces Two Presentations at Upcoming American College of Cardiology Scientific Sessions Business Wire
Jan-31-22 04:10PM	Tenax Therapeutics Appoints Robyn Hunter to the Board of Directors GlobeNewswire
Jan-12-22 08:30AM	Tenax Therapeutics Granted U.S. Patent for the Subcutaneous Use of Levosimendan (TNX-102) GlobeNewswire
Jan-05-22 11:48AM	TENX: TNX-103 & TNX-201 Near Ready for Phase III Zacks Small Cap Research
Jan-04-22 08:30AM	Tenax Therapeutics Provides Update on TNX-102, TNX-103 and TNX-201 Clinical Programs GlobeNewswire -9.01%
Nov-18-21 11:54AM	TENX: Imatinib IND Cleared & PK Study Near End Zacks Small Cap Research -5.22%
Nov-16-21 08:30AM	Tenax Therapeutics Reports Third Quarter 2021 Results and Provides Business Update Business Wire
Oct-06-21 08:30AM	Tenax Therapeutics Announces Clearance of the Investigational New Drug Application for Imatinib in Pulmonary Arterial Hypertension (PAH) Business Wire
Sep-28-21 08:30AM	Tenax Therapeutics to Present at the Benzinga Healthcare Small Cap Conference Business Wire +7.69%
10:43AM	Loading…
Sep-20-21 10:43AM	TENX: Second Quarter Results Zacks Small Cap Research -6.57%
Sep-09-21 08:00AM	Tenax Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference Business Wire
Aug-17-21 08:00AM	Tenax Therapeutics Reports Second Quarter 2021 Results and Provides Business Update Business Wire
Aug-12-21 08:00AM	Tenax Announces New Publication Highlighting Novel Levosimendan Mechanism of Action in Pulmonary Hypertension Patients with Heart Failure and Preserved Ejection Fraction (PH-HFpEF) Business Wire -5.49%
Aug-05-21 08:00AM	Tenax Therapeutics Announced KOL Webinar on Levosimendan for Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF) Business Wire +5.73%
Jul-16-21 12:40PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Tenax Therapeutics, Inc - TENX Newsfile
Jul-07-21 08:00AM	Tenax Therapeutics Announces CEO Transition and $10 Million PIPE Offering Priced At-the-Market under Nasdaq Rules Business Wire
Jun-14-21 04:25PM	Hedge Funds Are Selling Tenax Therapeutics Inc (TENX) Insider Monkey
Jun-10-21 08:30AM	Tenax Therapeutics Set to Join Russell Microcap® Index Business Wire
Jun-07-21 04:52PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Tenax Therapeutics, Inc - TENX Newsfile
May-17-21 05:15PM	Tenax Therapeutics Reports First Quarter 2021 Results and Provides Business Update Business Wire
Apr-14-21 07:45AM	TENX: HELP Results & New Asset to Boot Zacks Small Cap Research
Apr-09-21 11:38AM	Tenax Rises on Progress With Hypertension Treatment TheStreet.com +16.85%
08:00AM	Tenax Announces Publication Titled "Levosimendan Improves Hemodynamics and Exercise Tolerance in PH-HFpEF: Results of the Randomized Placebo-Controlled HELP Trial " Business Wire
Apr-07-21 04:45PM	Tenax Therapeutics Announces Continuation of Board Refreshment Program as Three Long-Serving Directors Volunteer to Not Stand for Re-Election at the Upcoming 2021 Annual Meeting of Stockholders Business Wire
Mar-31-21 04:45PM	Tenax Therapeutics Reports Fiscal Year 2020 Results and Provides Business Update Business Wire
Mar-04-21 08:30AM	Tenax Therapeutics to Present at the H.C. Wainwright Global Life Sciences Virtual Conference Business Wire -10.60%
Mar-02-21 08:15AM	Tenax Therapeutics, Inc. Expands Board of Directors Business Wire
Jan-20-21 10:30AM	TENX: Tenax Picks Up PH Precision Med Zacks Small Cap Research
07:45AM	Tenax Therapeutics Schedules Conference Call to Discuss Its Transformative Acquisition of PH Precision Med Business Wire
Jan-19-21 07:45AM	Tenax Therapeutics, Inc. Announces Transformative Acquisition of PH Precision Med Business Wire +32.58%
Dec-29-20 04:29PM	5 Top Stock Gainers for Tuesday: Snap, Barnes & Noble Education TheStreet.com +85.05%
10:12AM	Benzinga's Top Upgrades, Downgrades For December 29, 2020 Benzinga
Dec-03-20 07:47AM	TENX: FDA Meetings for Phase 3 Design Zacks Small Cap Research +17.14%
Nov-29-20 07:28PM	Is Tenax Therapeutics Inc (TENX) A Good Stock To Buy? Insider Monkey
Nov-16-20 04:45PM	Tenax Therapeutics Reports Third Quarter 2020 Results and Provides Business Update Business Wire
Nov-10-20 08:30AM	Tenax Therapeutics Announces Presentation of 24-Hour HELP Study Results at the American Heart Association Scientific Sessions 2020 Business Wire
Nov-06-20 08:30AM	Tenax Therapeutics to Host Virtual R&D Webinar with Scientific Experts Highlighting HELP Study Results Business Wire +7.80%
Oct-15-20 08:30AM	Tenax Therapeutics Gains North American Rights to Oral Levosimendan through Expanded License Agreement with Orion Corporation Business Wire +8.06%
Oct-02-20 08:30AM	Tenax Therapeutics Announces Late-Breaking Clinical Trial Presentation of Phase 2 HELP Study at Heart Failure Society of America (HFSA) Virtual Annual Scientific Meeting Business Wire
Sep-01-20 10:44AM	Tenax Therapeutics to Present at H.C. Wainwright 22nd Annual Global Investment Conference Business Wire
Aug-31-20 08:30AM	Tenax Announces Late-Breaking Results from the HELP Study Accepted for Presentation at the Heart Failure Society of America (HFSA) Annual Scientific Meeting Business Wire
Aug-28-20 10:54AM	TENX: Upcoming FDA Meetings for Ph3 Design Zacks Small Cap Research
Aug-17-20 08:00AM	Tenax Therapeutics Reports Second Quarter 2020 Results and Provides Business Update Business Wire
Jul-20-20 08:45AM	Tenax Therapeutics Expands Board of Directors with the Appointment of Two New Directors, Steven Boyd and Keith Maher, MD Business Wire
Jul-06-20 07:50PM	Tenax Therapeutics Announces $8.0 Million Registered Direct and PIPE Offerings Priced At-the-Market Under Nasdaq Rules Business Wire
Jun-03-20 09:41AM	Company News for June 3, 2020 Zacks -8.54%
08:30AM	Tenax Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement Business Wire
Jun-02-20 07:30AM	Tenax Therapeutics Reports Positive Results from Phase 2 Trial of Levosimendan in Patients with Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction (PH-HFpEF) Business Wire +13.10%
Jun-01-20 05:30AM	TENX: Undiscovered Gem Zacks Small Cap Research
May-29-20 01:07PM	Hedge Funds Are Warming Up To Tenax Therapeutics Inc (TENX) Insider Monkey
Apr-13-20 05:55AM	TENX: Full Year 2019 Financial and Operational Review Zacks Small Cap Research
05:40AM	TENX: Full Year 2019 Financial and Operational Review Zacks Small Cap Research
Apr-09-20 08:30AM	Tenax Therapeutics Announces Last Patient Completes Final Visit in its Phase 2 "HELP Study" of Levosimendan for Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction Business Wire -6.66%
Mar-19-20 10:16AM	Companies Like Tenax Therapeutics (NASDAQ:TENX) Can Be Considered Quite Risky Simply Wall St.
Mar-12-20 08:30AM	Tenax Therapeutics Completes Enrollment in Phase 2 Pulmonary Hypertension Trial Business Wire -36.54%
08:00AM	Tenax Therapeutics Announces $2.75 Million Registered Direct Offering Priced At-the-Market Business Wire
Feb-21-20 08:30AM	Tenax Announces the Addition of Mayo Clinic Expert, Dr. Barry Borlaug, to Scientific Advisory Board Business Wire -5.84%
Jan-21-20 06:15AM	TENX: Enrollment Completion Expected 1Q:20 Zacks Small Cap Research +8.59%
Jan-13-20 08:30AM	Tenax Therapeutics Provides Update on Phase 2 Pulmonary Hypertension Clinical Trial Business Wire -7.91%
Dec-20-19 12:03PM	Does Tenax Therapeutics, Inc. (NASDAQ:TENX) Have A Particularly Volatile Share Price? Simply Wall St.
Nov-04-19 10:45AM	TENX: Tenax HELP Update Zacks Small Cap Research
Oct-31-19 08:00AM	Tenax Therapeutics Provides Update on Phase 2 Pulmonary Hypertension Clinical Trial Business Wire +7.44%
Sep-20-19 03:11PM	We're A Little Worried About Tenax Therapeutics's (NASDAQ:TENX) Cash Burn Rate Simply Wall St.
Sep-12-19 09:15AM	TENX: Focused on the Enrollment Phase Zacks Small Cap Research
Aug-29-19 08:00AM	Tenax Therapeutics to Present at H.C. Wainwright 21st Annual Global Investment Conference Business Wire
Aug-23-19 08:00AM	Tenax Therapeutics Provides Clinical Development Update Business Wire +5.94%
Jul-16-19 12:23PM	What Kind Of Investor Owns Most Of Tenax Therapeutics, Inc. (NASDAQ:TENX)? Simply Wall St.
Jun-12-19 11:25AM	TENX: Screening & Enrollment Continue Zacks Small Cap Research
Apr-11-19 10:15AM	TENX: HELP Trial Enrollment Underway Zacks Small Cap Research
Mar-11-19 03:20PM	Introducing Tenax Therapeutics (NASDAQ:TENX), The Stock That Collapsed 98% Simply Wall St. -10.55%
08:30AM	Tenax Therapeutics Enrolls First Patient for Phase 2 Pulmonary Hypertension Clinical Trial Business Wire
Feb-21-19 01:35PM	Four Biotech Stocks Setting The Standard On Thursday (2/21/19) ACCESSWIRE
Feb-04-19 08:30AM	Tenax Therapeutics to Present at 2019 BIO CEO & Investor Conference Business Wire +5.60%
Jan-04-19 08:30AM	Tenax Therapeutics to Present at Biotech Showcase Investor Conference Business Wire
Dec-11-18 04:00PM	Tenax Therapeutics Announces Closing of $10 Million Underwritten Offering Business Wire -9.02%
Dec-07-18 01:02PM	Tenax Therapeutics Announces Pricing of $10 Million Underwritten Offering Business Wire -17.26%
Nov-26-18 11:00AM	TENX: We Have Liftoff: HELP Site Activated Zacks Small Cap Research -19.69%
Nov-21-18 03:21PM	Heat Biologics Takes Beating After Pricing $12 Million Stock Offering TheStreet.com -19.44%
Nov-19-18 08:00AM	Tenax Therapeutics Activates First Clinical Research Site for Phase 2 Pulmonary Hypertension Clinical Trial Business Wire +5.00%

Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. It develops TNX-103 and TNX-102 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of pulmonary arterial hypertension. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Upgrade your FINVIZ experience